Korea Stock Market Wrap: KOSPI Bounces, KOSDAQ Still Struggles

This Korea stock market wrap begins with a divided market. The KOSPI recovered to 6,856.83, up 0.73%, while the KOSDAQ fell to 783.98, down 1.92%. After the previous session’s panic-driven decline, institutional and foreign buying returned to major semiconductor stocks. However, the recovery did not spread evenly across the market. Large-cap memory names stabilized, but weaker biotech sentiment and continued risk aversion kept the KOSDAQ under pressure.

1. Samsung Electronics and SK hynix Lead the Relief Bounce

Samsung Electronics rose 3.34%, while SK hynix gained 3.69%. Buying returned as investors focused on resilient memory prices, higher HBM production expectations, and continued capital spending by global technology companies. The rebound suggested that the previous session’s collapse reflected forced selling and fear more than a sudden breakdown in AI-memory demand.

Still, one positive session does not repair the chart overnight. Investors now need confirmation from earnings, memory pricing, foreign flows, and big-tech capital expenditure. The market has stopped shouting “fire,” but it has not yet put the fire extinguisher away.

2. Semiconductor Equipment and Materials Outperformed

The strongest semiconductor moves appeared in the supply chain. VM climbed 18.98%, TES rose 16.68%, TSE gained 10.58%, PSK advanced 10.24%, and Techwing increased 10.49%. Investors focused on order-backlog growth, stronger fab investment, and improving demand for inspection, deposition, cleaning, packaging, and testing equipment.

3. AI Data-Center Power Moves Into Distribution

Power infrastructure remained an important AI-related theme. Daewon Cable rose 17.84%, while GNC Energy gained 12.15%. Investors are increasingly looking beyond high-voltage transmission equipment toward distribution transformers, switchgear, backup generators, cables, and microgrids. These systems deliver electricity from the wider grid into servers, cooling equipment, and individual data-center buildings.

This shift matters because distribution infrastructure can represent a broader market than the transmission segment. As AI campuses become larger, reliable backup power and short delivery times may become just as important as headline transformer capacity.

4. Biotech and Special Situations Remained Highly Selective

Hyundai Pharm surged 29.84% as policy discussion reduced uncertainty surrounding mifepristone. Rokit Healthcare gained 23.16% on progress in regenerative-medicine clinical research, while Genomictree rose 9.36% following a regulatory milestone for its bladder-cancer diagnostic test.

Not every biotech name participated. Alteogen fell 11.69% as patent-related headlines weighed on sentiment. Elsewhere, food-price concerns lifted Hantop and Mirae Life Resources, while renewed Hormuz and shipping-risk headlines supported STX Green Logis and oil-sensitive stocks. The market was handing out rewards, but only after checking everyone’s invitation twice.

5. Investor Takeaway

The July 14 Korea stock market wrap shows stabilization rather than a confirmed trend reversal. KOSPI mega caps recovered, semiconductor equipment remained strong, and AI power infrastructure continued to attract attention. However, the weaker KOSDAQ and uneven biotech performance show that risk appetite remains fragile.

Investors should watch whether foreign inflows persist, Samsung Electronics and SK hynix hold their rebound, and semiconductor-equipment orders convert into earnings. In the current market, companies with visible contracts, pricing power, capacity expansion, or regulatory catalysts deserve more attention than stocks rising only because the market needed a breather.

Related Reading and Official Market Resources